Clinical Trials List
2024-06-01 - 2027-12-31
Phase III
Recruiting4
ICD-10E78.0
Pure hypercholesterolemia
ICD-9272.0
Pure hypercholesterolemia
-
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/16
Investigators and Locations
Co-Principal Investigator
- Ming-Shien Wen 無
- 陳俊吉 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 李文煌 無
- Po-Sheng Chen 無
- 張獻元 無
- 黃鼎鈞 無
- 柯呈諭 無
- 黃睦翔 無
- Po-Tseng Lee 無
- Po Wei Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 蘇冠伃 無
- Chin-Sung Kuo 無
- 吳崇暉 無
- 蘇冠伃 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
60 participants
-
Global
300 participants
